ArticleCancer medicine2026
Integration of HIV Status in Cancer Surveillance in South Africa: A Call for Action.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundHuman immunodeficiency virus (HIV) increases the risk of developing cancer. We aimed to assign HIV status to cancers diagnosed in public laboratories recorded in the National Cancer Registry (NCR) in South Africa, guided by HIV counselling and testing guidelines.
methodsWe used natural language processing to extract HIV-related information from free-text reports and probabilistic record linkage to match cancers diagnosed between 2004 and 2021 to HIV-related tests from the National Health Laboratory Service Corporate Data Warehouse. We assigned HIV status based on the results of the HIV-related tests and their timing relative to cancer diagnosis. We used descriptive statistics and logistic regression to examine HIV status documentation patterns and HIV prevalence in cancer patients.
resultsOf the 496,517 cancers reported to the NCR, 41% (n = 203,937) had a documented HIV status. Documentation increased from 29% in 2004-2009 to 52% in 2016-2021. The odds of having a documented HIV status were 20% higher in females than in males and 16%-28% lower in other population groups compared with Black Africans. Patients with infection-related cancers had almost threefold higher odds of having a documented HIV status than patients with infection-unrelated cancers. Among cancer patients with documented HIV status, HIV prevalence was 75% for infection-related and 32% for infection-unrelated cancers.
conclusionHIV status documentation among people with cancer has improved over time, but it is still suboptimal. Clinicians and pathologists in HIV endemic areas need to improve HIV ascertainment at cancer diagnosis and reporting to cancer registries to inform patient care and guide cancer control efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.